liver cancer
Tencent Invests $30M in Early Cancer Detection Firm Insighta
Hong Kong-based Prenetics, which had a 50 percent stake in Insighta, sold some of its secondary shares and will now hold a 35 percent stake in the company.
Quest's Haystack Oncology, U of Montreal to Study Liquid Biopsy MRD Test in Colorectal Cancer
The partners will use Haystack's MRD test to assess treatment response and detect early relapse in colorectal cancer patients with liver metastasis.
The company recently published data on the MESA platform's ability to screen for colorectal cancer and is considering other testing opportunities.
Helio Genomics Sister Firm LAMH Receives NMPA Approval in China for Blood-Based Liver Cancer Test
The liquid biopsy assay is a modified version of Helio's HelioLiver test that is tailored to the unique genetic makeup of the Asia-Pacific population.
Liver Cancer Detection Score Developed With Machine Learning Analysis of Blood Plasma DNA Fragments
Researchers used machine learning to come up with a cell-free DNA 'fragmentome'-based score for finding hepatocellular carcinoma cases from blood plasma samples.